A scoring system to predict HBsAg seroclearance in hepatitis B and C coinfected patients treated with interferon and ribavirin in an Asian cohort

Current guidelines recommend that patients with hepatitis B virus-hepatitis C virus (HBV-HCV) coinfection be treated with direct anti-viral agents (DAAs). Compared with DAAs, pegylated interferon (PEG-IFN) and ribavirin therapy has the advantages of treating both viruses while maintaining an accepta...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, Yi-Hao, Kee, Kwong-Ming, Kuo, Fang-Ying, Chang, Kuo-Chin, Hu, Tsung-Hui, Lu, Sheng-Nan, Wang, Jing-Houng, Hung, Chao-Hung, Chen, Chien-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320125/
https://www.ncbi.nlm.nih.gov/pubmed/30557991
http://dx.doi.org/10.1097/MD.0000000000013383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320125/
https://www.ncbi.nlm.nih.gov/pubmed/30557991
http://dx.doi.org/10.1097/MD.0000000000013383

Ejemplares similares